$COGT

$30.91 -$0.30 (0.96%) Close

$COGT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$COGT Management Team

Dr. John Robinson

Chief Scientific Officer

Age 51

Compensation $1.807M USD

Sex Male

Mr. Cole Pinnow

Chief Commercial Officer

Age 50

Compensation $3.970M USD

Sex Male

Mr. Peter Harwin

Independent Chairman of the Board

Age 39

Compensation $382.1K USD

Sex Male

Mr. Andrew Robbins

Chief Executive Officer

President

Director

Age 49

Compensation $4.918M USD

Sex Male

Mr. John Green

Chief Financial Officer

Age 44

Compensation $1.748M USD

Sex Male

Dr. Jessica Sachs

Chief Medical Officer

Age 50

Compensation $1.833M USD

Sex Female

Mr. Evan Kearns

Chief Legal Officer

Corporate Secretary

Age 44

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Dr. John Robinson Chief Scientific Officer	51	$1.807M USD	Male
Mr. Cole Pinnow Chief Commercial Officer	50	$3.970M USD	Male
Mr. Peter Harwin Independent Chairman of the Board	39	$382.1K USD	Male
Mr. Andrew Robbins Chief Executive Officer President Director	49	$4.918M USD	Male
Mr. John Green Chief Financial Officer	44	$1.748M USD	Male
Dr. Jessica Sachs Chief Medical Officer	50	$1.833M USD	Female
Mr. Evan Kearns Chief Legal Officer Corporate Secretary	44	-	Male

Board of Directors

From the proxy statement filed Apr 23, 2026

Directors

serving now

Independent

6 of 6

stated in the proxy; 1 not stated

Average tenure

6.4 years

from year joined

CEO also chairs the board

Peter Harwin

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Andrew Robbins CEO	50	2020 6 years	Not stated	None stated	None stated	Paid as CEO
Chris Cain	42	2020 6 years	Independent	None stated	Jade Biosciences, Inc., Viridian Therapeutics, Inc., Damora Therapeutics, Inc.	Not stated
Karen Ferrante	68	2018 8 years	Independent	None stated	MacroGenics, Inc.	$247,115
Peter Harwin Board chair	40	2020 6 years	Independent	None stated	Crescent Biopharma, Inc., Apogee Therapeutics, Inc., Spyre Therapeutics, Inc., Oruka Therapeutics, Inc., Damora Therapeutics, Inc., Paragon Therapeutics, Inc.	$277,115
Arlene M. Morris	74	2019 7 years	Independent	None stated	Palatin Technologies, Inc., Viridian Therapeutics, Inc., Edgewise Therapeutics, Inc.	$254,615
Matthew E. Ros	59	2019 7 years	Independent	None stated	None stated	$244,615
Todd Shegog	61	2021 5 years	Independent	None stated	None stated	$257,115

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 23, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$COGT Management Team

Dr. John Robinson

Mr. Cole Pinnow

Mr. Peter Harwin

Mr. Andrew Robbins

Mr. John Green

Dr. Jessica Sachs

Mr. Evan Kearns

Board of Directors

Related-party transactions

No related-party transactions disclosed